ACCELERON PHARMA INC. Realized Gains on Marketable Securities
ACCELERON PHARMA INC. reported Realized Gains on Marketable Securities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2021-02-25
- ACCELERON PHARMA INC. marketable securities, realized gain (loss) for fiscal 2020 was $0.00.
- ACCELERON PHARMA INC. marketable securities, realized gain (loss) for fiscal 2019 was $0.00.
- ACCELERON PHARMA INC. marketable securities, realized gain (loss) for fiscal 2018 was $0.00.
- ACCELERON PHARMA INC. marketable securities, realized gain (loss) for fiscal 2017 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |